Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-01-27 12:22 pm Sale | 13G | Revance Therapeutics Inc. RVNC | JPMORGAN CHASE & CO JPM | 4,982,949 6% | -1,811,274 (-26.66%) | View |
2022-12-09 1:58 pm Purchase | 13G | Revance Therapeutics Inc. RVNC | Capital World Investors | 8,463,909 10.3% | 4,751,909 (+128.01%) | View |
2022-02-14 5:04 pm Purchase | 13G | Revance Therapeutics Inc. RVNC | Palo Alto Investors LP | 4,369,366 6.09% | 4,369,366 (New Position) | View |
2022-02-11 3:31 pm Purchase | 13G | Revance Therapeutics Inc. RVNC | Capital World Investors | 3,712,000 5.2% | 3,712,000 (New Position) | View |
2022-02-10 08:32 am Purchase | 13G | Revance Therapeutics Inc. RVNC | VANGUARD GROUP INC | 3,602,297 5.02% | 3,602,297 (New Position) | View |
2022-02-08 5:07 pm Purchase | 13G | Revance Therapeutics Inc. RVNC | GIC Private Ltd | 4,176,080 5.82% | 345,129 (+9.01%) | View |
2022-02-04 09:29 am Sale | 13G | Revance Therapeutics Inc. RVNC | WELLINGTON MANAGEMENT GROUP LLP | 1,104,531 1.54% | -2,293,341 (-67.49%) | View |
2022-02-03 4:41 pm Purchase | 13G | Revance Therapeutics Inc. RVNC | BlackRock Inc. BLK | 5,334,099 7.4% | 321,747 (+6.42%) | View |
2022-01-18 12:59 pm Purchase | 13G | Revance Therapeutics Inc. RVNC | JPMORGAN CHASE & CO JPM | 6,794,223 9.4% | 2,727,181 (+67.06%) | View |
2021-02-16 1:29 pm Sale | 13G | Revance Therapeutics Inc. RVNC | ArrowMark Colorado Holdings LLC | 2,964,135 4.5% | -1,876,501 (-38.77%) | View |
2021-02-12 4:32 pm Purchase | 13G | Revance Therapeutics Inc. RVNC | GIC Private Ltd | 3,830,951 5.76% | 865,400 (+29.18%) | View |
2021-02-10 06:01 am Sale | 13G | Revance Therapeutics Inc. RVNC | Essex Woodlands Health Ventures VIII L.L.C. | 457,085 0.007% | -2,884,962 (-86.32%) | View |
2021-02-05 07:51 am Purchase | 13G | Revance Therapeutics Inc. RVNC | BlackRock Inc. BLK | 5,012,352 7.5% | 1,323,695 (+35.89%) | View |
2021-02-04 11:42 am Sale | 13G | Revance Therapeutics Inc. RVNC | WELLINGTON MANAGEMENT GROUP LLP | 3,397,872 5.11% | -345,828 (-9.24%) | View |
2021-02-02 2:44 pm Sale | 13G | Revance Therapeutics Inc. RVNC | FRANKLIN RESOURCES INC BEN | 1,755,863 2.6% | -1,827,109 (-50.99%) | View |
2021-01-29 09:25 am Purchase | 13G | Revance Therapeutics Inc. RVNC | JPMORGAN CHASE & CO JPM | 4,067,042 6.1% | 38,545 (+0.96%) | View |
2020-08-10 09:43 am Sale | 13G | Revance Therapeutics Inc. RVNC | WELLINGTON MANAGEMENT GROUP LLP | 3,743,700 5.68% | -2,044,345 (-35.32%) | View |
2020-03-13 4:22 pm Purchase | 13G | Revance Therapeutics Inc. RVNC | GIC Private Ltd | 2,965,551 5.21% | 2,965,551 (New Position) | View |
2020-02-14 4:40 pm Sale | 13G | Revance Therapeutics Inc. RVNC | ArrowMark Colorado Holdings LLC | 4,840,636 9.57% | -39,292 (-0.81%) | View |
2020-02-06 09:10 am Purchase | 13G | Revance Therapeutics Inc. RVNC | BlackRock Inc. BLK | 3,688,657 7.2% | 482,057 (+15.03%) | View |